Search

Author/Creator Champion, R.

2. S258: LISOCABTAGENE MARALEUCEL (LISO-CEL) AS SECOND-LINE THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL) IN PATIENTS NOT INTENDED FOR HSCT: PRIMARY ANALYSIS FROM THE PHASE 2 PILOT STUDY. (23rd June 2022)

Authors:
Sehgal, A.; Hoda, D.; Riedell, P. A.; Ghosh, N.; Hamadani, M.; Hildebrandt, G. C.; Godwin, J. E.; Reagan, P.; Wagner-Johnston, N.; Essell, J.; Nath, R.; Solomon, S. R.; Champion, R.; Licitra, E.; Fanning, S.; Gupta, N.; Dubowy, R.; D'Andrea, A.; Wang, L.; Gordon, L. I.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search